Cystic fibrosis-related diabetes testing in Bosa
Find health labs to test for Cystic fibrosis-related diabetes in Bosa and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Diabetes Test by CDR Laboratorio di analisi
Via Zagabria, 60, 09129 Cagliari CA, Italia
81.7 km
Hemoglobin Test by Montalto Ckech-up s.r.l.
Strada Statale Castrense Campo Morto, 312, 01014 Montalto di Castro VT, Italia
214.7 km
Unverified
A Diabetes Test costs €50.00
See Details
Hemoglobin Test by Analisi Cliniche Prospero Colonna Srl
Corso Duca di Genova, 26, 00121 Roma RM, Italia
234.9 km
Unverified
A Diabetes Test costs €30.00
See Details
Hemoglobin Test by IKON ACILIA
Via di Prato Cornelio, 200, 00125 Roma RM, Italia
234.9 km
Diabetes Test by Centro Ricerche Cliniche- Alliance Medical Diagnostic
Via Cicerone, 15, 00071 Pomezia RM, Italia
229.3 km
Diabetes Test by Ospedale San Giovanni Battista ACISMOM
Via Luigi Ercole Morselli, 13, 00148 Roma RM, Italia
234.9 km
Diabetes Test by Farmacia Internazionale di Pierandrea Cicconetti & C. Snc
Piazza Pia, 11, 00042 Anzio RM, Italia
229.9 km
Diabetes Test by Centro Analisi Sim.O. Srl
Viale Antium, 6, 00042 Anzio RM, Italia
229.9 km
Unverified
A Diabetes Test costs €15.00
See Details
Diabetes Test by Lafarmacia.Tomaselli
Viale Beata Vergine del Carmelo, 75, 00144 Roma RM, Italia
234.9 km
Diabetes Test by Villa Sandra S.p.A.
Via Portuense, 798, 00148 Roma RM, Italia
234.9 km
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
